Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-08-09
2005-08-09
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
06927231
ABSTRACT:
The present invention relates to a method of amelioring oxidative stress and stress-related degenerative processes associated with aging or various disease conditions such as cancer, neurodegenerative diseases or the dysregulation of redox-regulated physiological processes, as indicated by the prooxidative shift in the plasma thil/disulfide redox state and its consequences in conditions of elevated oxidative stress, characterized by administering creatine.
REFERENCES:
patent: 5219846 (1993-06-01), Bru et al.
patent: WO 94/16712 (1994-08-01), None
patent: WO 98/43617 (1998-10-01), None
patent: WO 99/51097 (1999-10-01), None
The therapeutic potential of oral creatine supplementation in muscle disease, WYSS, et al., Medical Hypotheses, Eden Press (no date available).
2458781 Canada Inc.
Henley III Raymond J.
Schweitzer Cornman Gross & Bondell LLP
LandOfFree
Use of creatine for the amelioration of oxidative stress does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of creatine for the amelioration of oxidative stress, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of creatine for the amelioration of oxidative stress will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3462284